English: A female mosquito of the Culicidae family (Culiseta longiareolata). Size: about 10mm length Location: Lisbon region, Portugal Türkçe: Culiseta longiareolata türü di?i bir sivrisinek. (Photo credit: Wikipedia)
Vectored immunoprophylaxis (VIP) injection triggers creation of antibodies that prevent malaria in 70 percent of mice
A study led by Johns Hopkins Bloomberg School of Public Health researchers found that injecting a vaccine-like compound into mice was effective in protecting them from malaria. The findings suggest a potential new path toward the elusive goal of malaria immunization.
Mice injected with a virus genetically altered to help the rodents create an antibody designed to fight the malaria parasite produced high levels of the anti-malaria antibody. The approach, known as Vector immunoprophylaxis, or VIP, has shown promise in HIV studies. It had never before been tested with malaria, for which no licensed vaccine exists.
A report on the research appears online Aug. 11 in the Proceedings of the National Academy of Sciences (PNAS).
Malaria is one of the world’s deadliest infectious diseases, killing as many as 1 million people per year, the majority of them children in Africa. Malaria patients get the disease from infected mosquitoes. Of the four types of malaria that affect humans, the parasite Plasmodium falciparum is the most lethal, responsible for the majority of malaria cases. Antimalarial treatments and mosquito habitat modification have contributed to a decline in malaria mortality. But the number of cases remains high, and stemming them is a top global health priority.
In their study, researchers used a virus containing genes that were encoded to produce an antibody targeted to inhibit P. falciparum infection. Up to 70 percent of the mice injected with the VIP were protected from malaria-infected mosquito bites. In a subset of mice that produced higher levels of serum antibodies, the protection was 100 percent. The mice were tested a year after receiving a single injection of the virus and were shown to still produce high levels of the protective antibody.
The Latest on: Malaria vaccine
[google_news title=”” keyword=”Malaria vaccine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Malaria vaccine
- The Oxford R21 malaria vaccine and the imperative of continued malaria testingon December 6, 2023 at 1:33 am
Oxford R21 represents a significant step forwards in the fight against malaria, offering hope for a future with reduced malaria-related suffering and deaths. However, it is crucial to recognise that ...
- New technique developed to rapidly detect genetic changes in malaria parasiteson December 3, 2023 at 10:28 pm
Scientists have developed a technique to rapidly and reliably detect genetic changes in malaria parasites in Ghana, using just a gaming laptop and portable MinION sequencer from Oxford Nanopore.
- Can malaria vaccine pass hesitancy test?on December 1, 2023 at 10:14 pm
Health Sector Performance Report for 2022/2023 revealed major causes of deaths, with malaria on top, accounting for 4,245 deaths, which is 7.7 percent of total deaths ...
- Climate change risks upending global fight against malaria: WHOon December 1, 2023 at 4:21 pm
Climate change and its impacts, particularly extreme weather and heatwaves, pose a “substantial risk” to progress being made to fight malaria, the UN World Health Organization (WHO) said on Thursday.
- Climate change drives deadly malaria surge as elimination efforts reach ‘crunch point’on December 1, 2023 at 4:16 am
There are, however, also grounds for optimism. The first WHO-recommended malaria vaccine, RTS,S/AS01, is being rolled out and is available in three African countries, Ghana, Kenya and Malawi, and has ...
- Kenya spearheads malaria vaccine triumphon November 30, 2023 at 10:57 pm
Malaria burden is the highest on the African continent, which accounts for approximately 95% of global malaria cases and 96 percent of related deaths in 2021.
- Climate change risks upending global fight against malariaon November 30, 2023 at 10:10 pm
Climate change and its impacts, particularly extreme weather and heatwaves, pose a “substantial risk” to progress being made to fight malaria, the UN World Health Organization (WHO) said on Thursday.
- Cameroon Battles Malaria Vaccine Hesitancyon November 30, 2023 at 8:50 am
Cameroon’s Health Minister Dr Manaouda Malachie has urged the population to trust the government’s health policy, amid growing scepticism over the malaria vaccines which arrived in the country nine ...
- A New mRNA Malaria Vaccineon November 30, 2023 at 7:14 am
By targeting resident memory T cells in the liver, a novel mRNA malaria vaccine prevented infection, even in those with prior exposure.
- Malaria Vaccine To Be Available In Cameroon By 2024.on November 30, 2023 at 4:37 am
On Wednesday, the United Nations announced the upcoming expansion of malaria vaccination efforts throughout Africa, following the arrival of the first shipment of doses in Cameroon. The pilot phase, ...
via Bing News
